Repurposing screen identifies mebendazole as a clinical candidate to synergise with docetaxel for prostate cancer treatment

科研成果: 期刊稿件 › 文章 › 同行评审

31 引用 （Scopus）

指纹

探究 'Repurposing screen identifies mebendazole as a clinical candidate to synergise with docetaxel for prostate cancer treatment' 的科研主题。它们共同构成独一无二的指纹。

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science